University of Miami Health System, Miller School of Medicine

University of Miami Treats COVID-19 Patients with MSC Stem Cells

For COVID-19 patients in severe respiratory distress, the University of Miami Miller School of Medicine now offers access to mesenchymal stem cell (MSC) treatments that may help fight the characteristic inflammation that accompanies the viral infection.

Newswise — For COVID-19 patients in severe respiratory distress, the University of Miami Miller School of Medicine now offers access to mesenchymal stem cell (MSC) treatments that may help fight the characteristic inflammation that accompanies the viral infection.

On April 5, the U.S. Food and Drug Administration (FDA) approved MSC treatments for seriously ill COVID-19 patients as an “expanded access compassionate use.” Since then, UM has provided clinicians in Miami and Maryland with MSCs taken from bone marrow and cultured at the Interdisciplinary Stem Cell Institute (ISCI) manufacturing lab. Six COVID-19 patients with serious breathing difficulties have shown improvement after receiving MSC infusions along with other treatments. The sixth patient, who was on ECMO, was recently injected at Jackson Memorial Hospital.

“Early reports from China indicated that MSCs could be helpful in treating COVID-19 patients in severe respiratory distress,” said Jose Guillermo Castro, M.D., professor of infectious diseases at the Miller School and director of the antibiotic stewardship program at UHealth Tower. “We offer that form of therapy through ISCI and are cautiously optimistic that it can be helpful.”

Aisha Khan, executive director of laboratory operations at ISCI, said MSCs can help address an immune system over-response to a COVID-19 infection called a “cytokine storm,” referring to small proteins that produce inflammation, damaging the lungs and other organs. “Stem cells don’t make the virus disappear, but they help the body fight this disease,” said Khan. “By suppressing the cytokine storm, they can help a patient regain breathing ability.”

On April 7, Sixto Alejandro Arias, M.D., an interventional pulmonologist with UHealth – the University of Miami Health System, gave an initial infusion of MSCs to a patient in his 40s, who tested positive for COVID-19 in mid-March and was admitted to UHealth Tower with severe respiratory problems.

“Stem cells have been widely used to treat interstitial lung disease, and we felt this could be a safe and helpful therapy,” said Dr. Arias. “He received other forms of treatment as well; we don’t know how much the MSCs helped his condition. But we are very gratified to see him improve, and he is now out of intensive care.” That patient has since been discharged from UHealth Tower.

In early April, ISCI shipped MSCs to clinicians at the University of Maryland who were treating two patients with no other options. Both initial patients and two additional patients did well, and their levels of inflammation went down, according to Khan.

“We are so pleased to be able to offer this experimental therapy, working closely with our colleagues on the front lines taking care of these critically ill patients,” said Joshua M. Hare, M.D., Louis Lemberg Professor of Medicine and founding director of ISCI.

Khan said ISCI is making both bone marrow and umbilical cord-derived MSCs available for treating COVID-19 patients throughout South Florida. The FDA recently approved a clinical trial led by UM’s Diabetes Research Institute and Cell Transplant Center that will test the safety and effectiveness of umbilical cord-derived MSCs.

“Our staff members are working night and day to build our inventory, and we now have the ability to treat about 50 patients,” Khan said. “We plan to continue growing our inventory because the need for COVID-19 treatments is so great.”




Filters close

Showing results

110 of 3409
Newswise: Last-resort life support option helped majority of critically ill COVID-19 patients survive, global study shows
24-Sep-2020 3:20 PM EDT
Last-resort life support option helped majority of critically ill COVID-19 patients survive, global study shows
Michigan Medicine - University of Michigan

It saved lives in past epidemics of lung-damaging viruses. Now, the life-support option known as ECMO appears to be doing the same for many of the critically ill COVID-19 patients who receive it. Patients in a new international study faced a staggeringly high risk of death, as ventilators failed to support their lungs. But after they were placed on ECMO, their actual death rate was less than 40%.

Released: 25-Sep-2020 5:05 PM EDT
Case Western Reserve University researchers to examine how COVID-19 ravaged America’s nursing homes
Case Western Reserve University

Within a few months, federal officials reported that one of every five nursing homes had experienced a death from the novel coronavirus. Not long after, several media outlets published independent analysis finding that an estimated 40% of the fatalities related to COVID-19 took place in nursing homes. Rather than surrender to the terrifying trend, Case Western Reserve researchers saw an opportunity to help.

Released: 25-Sep-2020 4:15 PM EDT
Faced with pandemic shortages, researchers combine heat and humidity to disinfect N95 masks for reuse
SLAC National Accelerator Laboratory

They found that gently heating N95 masks in high relative humidity could inactivate SARS-CoV-2 virus trapped within the masks, without degrading the masks’ performance.

Released: 25-Sep-2020 3:30 PM EDT
Team assessing if dual-antibody injection prevents COVID-19 illness
University of Texas Health Science Center at Houston

A combination antibody treatment for preventing COVID-19 illness in individuals who have had sustained exposure to someone with the virus is being studied by researchers at The University of Texas Health Science Center at Houston (UTHealth). The clinical trial is enrolling patients at Harris Health System’s Lyndon B. Johnson Hospital.

Released: 25-Sep-2020 2:30 PM EDT
Yes, Wisconsin Republicans have the power to overturn the extended mask mandate order by Governor Evers
Newswise

Republicans have the legal power to reverse the order by Wisconsin Governor Tony Evers that extends the mask mandate.

Released: 25-Sep-2020 1:55 PM EDT
How do Americans view the virus? Anthropology professor examines attitudes of COVID
Northern Arizona University

In her ongoing research about Americans' responses to the COVID-19 pandemic, Northern Arizona University anthropology professor Lisa Hardy and her collaborators have talked to dozens of people.

Released: 25-Sep-2020 12:55 PM EDT
During pandemic, racism puts additional stress on Asian Americans
Massachusetts General Hospital

Many people are feeling anxious during these uncertain times as they navigate the risks associated with COVID-19 and experience the tension from physical distancing or isolation for what can seem like an eternity.

Released: 25-Sep-2020 12:55 PM EDT
COVID-19 shapes political approval ratings
University of North Carolina at Chapel Hill

Approval ratings of political leaders surged in the early days of the COVID-19 pandemic, according to a new study published in the Proceedings of the National Academy of Sciences.

Released: 25-Sep-2020 12:40 PM EDT
ASU Researchers Receive $6m State Contract to Develop Rapid, 20-Minute Covid-19 Saliva Test
Arizona State University (ASU)

As the world manages through the coronavirus pandemic, Arizona State University continues its work to discover and develop easier and more widespread COVID-19 testing to assist in managing the virus.

Released: 25-Sep-2020 11:55 AM EDT
Scholars untangle marketing's complex role in understanding political activities
American Marketing Association (AMA)

As 2020 began, many pundits predicted a politically charged year, but few predicted that it would include a global pandemic overtaxing healthcare resources, strained U.S. race relations resulting in mass demonstrations across the globe, devastating fires consuming massive swaths of the United States, and a catastrophic global economic downturn.


Showing results

110 of 3409

close
2.5472